- Home
- UVE vs TERN Comparison
UVE vs TERN Comparison
Compare UVE & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UVE
- TERN
- Stock Information
- Founded
- UVE 1990
- TERN 2017
- Country
- UVE United States
- TERN United States
- Employees
- UVE N/A
- TERN N/A
- Industry
- UVE Property-Casualty Insurers
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- UVE Finance
- TERN Health Care
- Exchange
- UVE Nasdaq
- TERN Nasdaq
- Market Cap
- UVE 666.1M
- TERN 634.5M
- IPO Year
- UVE 1992
- TERN 2021
- Fundamental
- Price
- UVE $25.50
- TERN $7.37
- Analyst Decision
- UVE
- TERN Buy
- Analyst Count
- UVE 0
- TERN 6
- Target Price
- UVE N/A
- TERN $13.99
- AVG Volume (30 Days)
- UVE 139.0K
- TERN 1.1M
- Earning Date
- UVE 10-23-2025
- TERN 11-11-2025
- Dividend Yield
- UVE 3.10%
- TERN N/A
- EPS Growth
- UVE N/A
- TERN N/A
- EPS
- UVE 2.28
- TERN N/A
- Revenue
- UVE $1,567,371,000.00
- TERN N/A
- Revenue This Year
- UVE $1.87
- TERN N/A
- Revenue Next Year
- UVE N/A
- TERN N/A
- P/E Ratio
- UVE $10.89
- TERN N/A
- Revenue Growth
- UVE 5.64
- TERN N/A
- 52 Week Low
- UVE $16.50
- TERN $1.87
- 52 Week High
- UVE $28.49
- TERN $11.00
- Technical
- Relative Strength Index (RSI)
- UVE 59.19
- TERN 58.60
- Support Level
- UVE $24.13
- TERN $6.78
- Resistance Level
- UVE $25.67
- TERN $7.67
- Average True Range (ATR)
- UVE 0.58
- TERN 0.44
- MACD
- UVE 0.12
- TERN -0.03
- Stochastic Oscillator
- UVE 77.37
- TERN 59.29
About UVE UNIVERSAL INSURANCE HOLDINGS INC
Universal Insurance Holdings Inc is a private personal residential homeowner insurance company. The company develops, markets, and underwrites insurance products for consumers predominantly in the personal residential homeowners' lines of business and performs substantially all other insurance-related services for its primary insurance entities, including risk management, claims management, and distribution. The company generates revenue from the collection of premiums, earned net interest and dividend income from the investment portfolio, the collection of reinsurance recoverable and financing fees. The company's primary insurance subsidiaries, (UPCIC) and (APPCIC) provide insurance for personal residential: homeowners, renters/tenants, condo unit owners, and other related coverages.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.